Results 131 to 140 of about 319,380 (216)

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review. [PDF]

Immun Inflamm Dis
Pang M, Li L, Zhang Q, Zhao M.
europepmc   +1 more source

Association between adiposity and psoriatic arthritis beyond classical clinical predictors. [PDF]

Clin Rheumatol
Pardo E, Burger S, Loredo M, Braña I, Alvarez P, Queiro R.   +5 more
europepmc   +1 more source

Patients with Psoriatic Arthritis Have Increased Dental Comorbidities: A Nationwide Population-based Cohort Study in Korea. [PDF]

Acta Derm Venereol
Kong S, Kim KE, Kwak EJ, Kim HN, Kim A, Jeon J, Park CM, Baek YS.   +7 more
europepmc   +1 more source

Beyond Pain Intensity: The Relationship Between Pain Catastrophizing and Quality of Life in Psoriatic Arthritis. [PDF]

J Rheumatol
Chen K, Scher U, Scher JU, Haberman RH.
europepmc   +1 more source

Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Response to Letter]. [PDF]

Drug Des Devel Ther
Yen FS, Wang SI, Hwu CM, Chen KY, Hsu CC, Wei JC.   +5 more
europepmc   +1 more source

Skewed MHC Class I Peptide Presentation in Psoriatic Arthritis. [PDF]

Int J Mol Sci
Comdühr S, Sauer T, Deckert S, Pitann S, Schäfer M, Gemoll T, Arnold S, Klapa S, Riemekasten G, Thaçi D, Graßhoff H, Lamprecht P.   +11 more
europepmc   +1 more source

Editorial: The Path in Psoriatic Disease-From Conceptual Clarity to Clinical Translation. [PDF]

Int J Rheum Dis
Huo AP, Cheng TK, Wei JC.
europepmc   +1 more source

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase. [PDF]

Rheumatology (Oxford)
Macleod T, Dubash SR, Hyde I, Michelena X, Berekmeri A, Helliwell PS, Kingsbury SR, Laws P, Mankia K, Stacey M, Marzo-Ortega H, Wittmann M.   +11 more
europepmc   +1 more source

Clinical and imaging characteristics of patients with axial psoriatic arthritis: Baseline findings from the GESPIC-axial-PsA cohort. [PDF]

Ther Adv Musculoskelet Dis
Baum H, Torgutalp M, Rios Rodriguez V, Rademacher J, Protopopov M, Haibel H, Muche B, Hermann KG, Poddubnyy D, Proft F.   +9 more
europepmc   +1 more source

Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Letter]. [PDF]

Drug Des Devel Ther
Lymperopoulos A, Leiker MG.
europepmc   +1 more source